Biotech RadarJobs updated

COMPANY

MDI Therapeutics Inc.

HQ: Novi, MI source · mditherapeutics.com ↗

Clinical Phase 1

Keywords: fibrosis Safety After Oral Intake Safety and Tolerability MDI-2517

Location: Novi, MI · source · Oct 13, 2026

Profile checked Oct 10, 2026

2Trials (company is sponsor)

Timeline

  1. Trial start Phase 1: Single Ascending Dose and Multiple Ascending Dose Evaluation of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MDI-2517 in Healthy Participants source ↗
  2. Trial start Phase 1: SAD Evaluation of Safety, Tolerability, PK, and PD of MDI-2517 in Healthy Participants source ↗

Clinical trials (lead sponsor) 2

RecordTitlePhaseStatusStartPrimary completion
NCT07220889Single Ascending Dose and Multiple Ascending Dose Evaluation of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MDI-2517 in Healthy ParticipantsPhase 1CompletedNov 4, 2025Dec 16, 2025 (actual)
NCT06453824SAD Evaluation of Safety, Tolerability, PK, and PD of MDI-2517 in Healthy ParticipantsPhase 1CompletedMay 17, 2024Nov 11, 2024 (actual)
Feedback